Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianjun He

Showing results (211-220 of 217) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 217 results.
Frontiers in Oncology|March 1, 2021
Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer: A Nation-Wide Multicenter Epidemiological Study in ChinaYun Wu, Yiqun Han, Pei Yu, et al.
Breast (Edinburgh, Scotland)|January 26, 2024
Axillary lymph node dissection in triple-negative or HER2-positive breast cancer patients with clinical N2 achieving pathological complete response after neoadjuvant therapy: Is it necessary?Xuhui Guo, Jiao Zhang, Xilong Gong, et al.
Cancer Medicine|September 2, 2021
Profile, treatment patterns, and influencing factors of anthracycline use in breast cancer patients in China: A nation-wide multicenter studyFengzhu Guo, Zongbi Yi, Wenna Wang, et al.
Chinese Medical Journal|October 26, 2023
Association of a complete breast cancer pathologic response with axillary lymph node metastasis via neoadjuvant chemotherapy: Results from the CSBrS-012 studyLe Ma, Pin Gao, Zhenzhen Liu, et al.
Nature|October 26, 2022
Measurement of <sup>19</sup>F(p, γ)<sup>20</sup>Ne reaction suggests CNO breakout in first starsLiyong Zhang, Jianjun He, Richard J deBoer, et al.
Oncology Letters|May 29, 2018
Multicenter cross-sectional screening of the <i>BRCA</i> gene for Chinese high hereditary risk breast cancer populationsHongyi Wei, Minghao Wang, Jianghua Ou, et al.
Science Bulletin|December 22, 2022
First result from the Jinping Underground Nuclear Astrophysics experiment JUNA: precise measurement of the 92 keV <sup>25</sup>Mg(p, γ)<sup>26</sup>Al resonanceJun Su, Hao Zhang, Zhihong Li, et al.
Pageof 22

Showing results (211-220 of 217) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 217 results.
Frontiers in Oncology|March 1, 2021
Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer: A Nation-Wide Multicenter Epidemiological Study in ChinaYun Wu, Yiqun Han, Pei Yu, et al.
Breast (Edinburgh, Scotland)|January 26, 2024
Axillary lymph node dissection in triple-negative or HER2-positive breast cancer patients with clinical N2 achieving pathological complete response after neoadjuvant therapy: Is it necessary?Xuhui Guo, Jiao Zhang, Xilong Gong, et al.
Cancer Medicine|September 2, 2021
Profile, treatment patterns, and influencing factors of anthracycline use in breast cancer patients in China: A nation-wide multicenter studyFengzhu Guo, Zongbi Yi, Wenna Wang, et al.
Chinese Medical Journal|October 26, 2023
Association of a complete breast cancer pathologic response with axillary lymph node metastasis via neoadjuvant chemotherapy: Results from the CSBrS-012 studyLe Ma, Pin Gao, Zhenzhen Liu, et al.
Nature|October 26, 2022
Measurement of <sup>19</sup>F(p, γ)<sup>20</sup>Ne reaction suggests CNO breakout in first starsLiyong Zhang, Jianjun He, Richard J deBoer, et al.
Oncology Letters|May 29, 2018
Multicenter cross-sectional screening of the <i>BRCA</i> gene for Chinese high hereditary risk breast cancer populationsHongyi Wei, Minghao Wang, Jianghua Ou, et al.
Science Bulletin|December 22, 2022
First result from the Jinping Underground Nuclear Astrophysics experiment JUNA: precise measurement of the 92 keV <sup>25</sup>Mg(p, γ)<sup>26</sup>Al resonanceJun Su, Hao Zhang, Zhihong Li, et al.
Pageof 22